Roche (SIX: RO, ROG; OTCQX: RHHBY) has received FDA approval to expand the use of two companion diagnostic tests to ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE